Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 30;52(3):191-196.
doi: 10.28920/dhm52.3.191-196.

Pretreatment hearing grades and hearing recovery outcomes after primary hyperbaric oxygen treatment in patients with idiopathic sudden sensorineural hearing loss

Affiliations

Pretreatment hearing grades and hearing recovery outcomes after primary hyperbaric oxygen treatment in patients with idiopathic sudden sensorineural hearing loss

Andrijana Včeva et al. Diving Hyperb Med. .

Abstract

Introduction: Previous studies suggest the effectiveness of hyperbaric oxygen treatment (HBOT) in idiopathic sudden sensorineural hearing loss (ISSNHL) but it is mostly used as an adjuvant and salvage treatment. This study evaluated the effect of primary HBOT according to pretreatment hearing grades and hearing recovery outcomes using modified Siegel's criteria in patients with ISSNHL.

Methods: Fifty-nine ISSNHL patients treated with only HBOT were included. A pure-tone audiogram was recorded before and after a course of HBOT (90 min at 203 kPa daily for 20 days). Using the modified Siegel's criteria, patients were divided into groups according to hearing threshold before and after treatment.

Results: Hearing thresholds were significantly lower after HBOT compared to pre-treatment values across all patients (P < 0.001) with a median value of recovery of 22.5 dB (interquartile range 12.5-33.7 dB). Significantly lower hearing threshold values were recorded at 500, 1,000, 2,000, and 4,000 Hz after treatment (P < 0.001). The greatest recovery was at 1,000 Hz, (change in median threshold = 32 dB) but without a significant difference compared to other frequencies (P = 0.10).

Conclusions: HBOT is a legitimate choice as the primary treatment for ISSNHL, especially if it is readily accessible, and if there are contraindications for corticosteroid therapy.

Keywords: Clinical audit; Deafness; ENT; Hyperbaric research; Otorhinolaryngology; Outcome.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest and funding: nil

Similar articles

Cited by

References

    1. Chin CJ, Dorman K. Sudden sensorineural hearing loss. CMAJ. 2017;189:E437–8. doi: 10.1503/cmaj.161191. - DOI - PMC - PubMed
    1. Foden N, Mehta N, Joseph T. Sudden onset hearing loss - causes, investigations and management. Aust Fam Physician. 2013;42:641–4. - PubMed
    1. Leung MA, Flaherty A, Zhang JA, Hara J, Barber W, Burgess L. Sudden sensorineural hearing loss: primary care update. Hawaii J Med Public Health. 2016;75:172–4. - PMC - PubMed
    1. Passamonti SM, Di Berardino F, Bucciarelli p, Berto V, Artoni A, Gianniello F, et al. Risk factors for idiopathic sudden sensorineural hearing loss and their association with clinical outcome. Thromb Res. 2015;135:508–12. doi: 10.1016/j.thromres.2015.01.001. - DOI - PubMed
    1. Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1–S45. doi: 10.1177/0194599819859885. - DOI - PubMed

LinkOut - more resources